Eliot A. Brinton, MD, FAHA, FNLA, FACE, is a clinical lipidologist and endocrinologist specializing in cardiometabolic risk management. He is President of the Utah Lipid Center in Salt Lake City and Director of its LDL Apheresis Center, and he serves as adjunct faculty at the University of Utah School of Medicine and President of the Utah Atherosclerosis Society. His clinical focus includes complex lipid management, cardiometabolic risk reduction through nutrition and weight-focused care, and advanced lipid therapeutics including therapeutic apheresis. Dr. Brinton’s research interests center on human lipoprotein metabolism and kinetics, strategies to reduce residual cardiovascular risk, and cardiometabolic outcomes associated with emerging lipid and metabolic therapies. He has held national leadership roles as Past President of the American Board of Clinical Lipidology and the Pacific Lipid Association, and as a founding board member of the National Lipid Association. He serves in editorial leadership as Associate Editor for the Journal of Clinical Lipidology and Assistant Editor for the Journal of Obesity, and has contributed as an expert writer for professional society guidelines and scientific statements. His honors include the Robert I. Levy Award for excellence in human lipoprotein metabolism research. He earned his MD from the University of Utah School of Medicine, completed an Internal Medicine residency at Duke University Medical Center, and pursued fellowship training in Metabolism, Endocrinology & Nutrition at the University of Washington School of Medicine.
Adjunct Faculty
Medical School
1974 – 1978
Residency
1978 – 1981
Fellowship
1981 – 1984